Search Results 1121-1130 of 11220 for Antifungal Resistance

1. Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients - Mayo Clinic

   0 viral, bacterial, or fungal infection within 2 weeks of registration. 4. Patients who have a diagnosis of ocular, mucosal or acral melanoma. 5. Known ...

2. A Study To Evaluate The Effectiveness And Safety Of Bb2121 In Subjects With Relapsed And Refractory Multiple Myeloma And In Subjects With Clinical High-Risk Multiple Myeloma - Mayo Clinic

   This includes systemic fungal, bacterial, viral, or other infection that is uncontrolled (defined as exhibiting ongoing signs/symptoms related to the ...

3. Antidepressants and alcohol: What's the concern? - Mayo Clinic

   You may feel more depressed or anxious. Alcohol can stop the benefits of your antidepressant medicine, making your symptoms harder to treat. Alcohol may seem to ...

4. Drugs and Supplements that Start with F - Mayo Clinic

   Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “F” to learn about drug side effects, proper use and ...

5. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

   No active infection requiring systemic antibiotics, antiviral, or antifungal treatments. No history of allogeneic stem cell transplantation, or autologous ...

6. A Study Of SC-006 In Subjects With Advanced Cancer - Mayo Clinic

   Any active Grade 3 or higher viral, bacterial, or fungal infection within 2 weeks of the first dose of the study drug. Routine antimicrobial prophylaxis is ...

7. A Study To Evaluate Tucatinib Plus Trastuzumab And Oxaliplatin-based Chemotherapy For HER2+ Gastrointestinal Cancers - Mayo Clinic

   0) viral, bacterial, or fungal infection within 2 weeks prior to the first dose of study drug. Routine antimicrobial prophylaxis is permitted. Participating ...

8. FOG-001 In Locally Advanced Or Metastatic Solid Tumors - Mayo Clinic

   * Non-MSI-H or non-dMMR (by local testing) CRC with or without liver metastases. * MSI-H CRC or solid tumors that are WPAM and resistant to a-PD-1/PD-L1 * ...

9. Guard against contagious infections - Mayo Clinic

   Thank a researcher today ... Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.

10. A Study To Assess The Effectiveness And Safety Of REGN3500 Monotherapy And Combination Of REGN3500 Plus Dupilumab In Adult Patients With Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

    Active chronic or acute infection requiring treatment with systemic antibiotics, antivirals, antiparasitics, antiprotozoals, or antifungals within 2 weeks ...